118 related articles for article (PubMed ID: 8695269)
1. N-MYC amplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastoma.
Doz F; Peter M; Schleiermacher G; Vielh P; Validire P; Putterman M; Blanquet V; Desjardins L; Dufier JL; Zucker JM; Mosseri V; Thomas G; Magdelénat H; Delattre O
Eur J Cancer; 1996 Apr; 32A(4):645-9. PubMed ID: 8695269
[TBL] [Abstract][Full Text] [Related]
2. N-myc amplification was rarely detected by fluorescence in situ hybridization in retinoblastoma.
Kim JH; Choi JM; Yu YS; Kim DH; Kim JH; Kim KW
Hum Pathol; 2008 Aug; 39(8):1172-5. PubMed ID: 18538370
[TBL] [Abstract][Full Text] [Related]
3. Nonrandom chromosomal changes in retinoblastomas.
Pogosianz HE; Kuznetsova LE
Arch Geschwulstforsch; 1986; 56(2):135-43. PubMed ID: 3707294
[TBL] [Abstract][Full Text] [Related]
4. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
[TBL] [Abstract][Full Text] [Related]
6. Loss of retinoblastoma gene and amplification of N-myc gene in retinoblastoma.
Choi SW; Lee TW; Yang SW; Hong WS; Kim CM; Lee JO
J Korean Med Sci; 1993 Feb; 8(1):73-7. PubMed ID: 8343223
[TBL] [Abstract][Full Text] [Related]
7. Lack of interstitial chromosome 1p deletions in clinically-detected neuroblastoma.
Godfried MB; Veenstra M; Valent A; Sluis Pv; Voûte PA; Versteeg R; Caron HN
Eur J Cancer; 2002 Jul; 38(11):1513-9. PubMed ID: 12110498
[TBL] [Abstract][Full Text] [Related]
8. Increase in copy number of N-myc in retinoblastomas in comparison with chromosome abnormality.
Sakai K; Tanooka H; Sasaki MS; Ejima Y; Kaneko A
Cancer Genet Cytogenet; 1988 Jan; 30(1):119-26. PubMed ID: 3422037
[TBL] [Abstract][Full Text] [Related]
9. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
Bown N; Cotterill S; Lastowska M; O'Neill S; Pearson AD; Plantaz D; Meddeb M; Danglot G; Brinkschmidt C; Christiansen H; Laureys G; Speleman F; Nicholson J; Bernheim A; Betts DR; Vandesompele J; Van Roy N
N Engl J Med; 1999 Jun; 340(25):1954-61. PubMed ID: 10379019
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity for chromosome 1p in familial neuroblastoma.
Tonini GP; Lo Cunsolo C; Cusano R; Iolascon A; Dagnino M; Conte M; Milanaccio C; De Bernardi B; Mazzocco K; Scaruffi P
Eur J Cancer; 1997 Oct; 33(12):1953-6. PubMed ID: 9516831
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of Nmyc amplification and deletion of the short arm of chromosome 1 in neuroblastoma tumours: a single institution study.
Michon J; Delattre O; Zucker JM; Peter M; Delonlay P; Luciani S; Mosseri V; Vielh P; Neuenschwander S; Thomas G
Prog Clin Biol Res; 1994; 385():11-7. PubMed ID: 7972201
[No Abstract] [Full Text] [Related]
12. Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma. Complementary prognostic indicators.
Muraji T; Okamoto E; Fujimoto J; Suita S; Nakagawara A
Cancer; 1993 Nov; 72(9):2763-8. PubMed ID: 8402501
[TBL] [Abstract][Full Text] [Related]
13. Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastoma.
Christiansen H; Sahin K; Berthold F; Hero B; Terpe HJ; Lampert F
Eur J Cancer; 1995; 31A(4):541-4. PubMed ID: 7576963
[TBL] [Abstract][Full Text] [Related]
14. Expression and amplification of the N-myc gene in primary retinoblastoma.
Lee WH; Murphree AL; Benedict WF
Nature; 1984 May 31-Jun 6; 309(5967):458-60. PubMed ID: 6728001
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.
Fong CT; Dracopoli NC; White PS; Merrill PT; Griffith RC; Housman DE; Brodeur GM
Proc Natl Acad Sci U S A; 1989 May; 86(10):3753-7. PubMed ID: 2566996
[TBL] [Abstract][Full Text] [Related]
16. Genetics of embryonal tumours of childhood: retinoblastoma, Wilms' tumour and neuroblastoma.
Brodeur GM
Cancer Surv; 1995; 25():67-99. PubMed ID: 8718513
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma.
Kato MV; Shimizu T; Ishizaki K; Kaneko A; Yandell DW; Toguchida J; Sasaki MS
Cancer Lett; 1996 Aug; 106(1):75-82. PubMed ID: 8827049
[TBL] [Abstract][Full Text] [Related]
18. [Sensibility and specificity of N-myc oncogene with respect to other prognostic factors in 15 neuroblastomas].
Queizán A; García-Miguel P; Belló MJ; Castresana JC; Rey JA; Pestaña A
Cir Pediatr; 1995 Jul; 8(3):96-8. PubMed ID: 8527322
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity on chromosome 13 and its association with delayed growth of retinoblastoma.
Kato MV; Ishizaki K; Ejima Y; Kaneko A; Tanooka H; Sasaki MS
Int J Cancer; 1993 Jul; 54(6):922-6. PubMed ID: 8335400
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
